Synergistic antitumor effects of tumor necrosis factor ALPHA. and interleukin 2 mini-pellet

Tadashi Onoda, Kenichi Sakagami, Junji Matsuoka, Shigehiro Shiozaki, Susumu Uchida, Toshiyoshi Fujiwara, Kun Zou Orita, Keiji Fujioka, Yyshihiro Takada

Research output: Contribution to journalArticle

Abstract

Synergistic antitumor effects of tumor necrosis factor α and interleukin 2 mini-pellet We have investigated the antitomor effect of IL 2 mini pellet on the therapy of murine Meth-A sarcoma in these years. In this study we used IL-2 mini-pellet with a small dose of nHuTNF-α and examined of its antitumor efficacy compared with the administration of IL-2 mini-pellet alone. Even a single administration of IL-2 mini pellet alone could inhibited the growth of Meth-A sarcoma that had transplanted in mice, the combined use was more effective. The lytic activity of splenocytes against YAC-1 cells was prolonged in the combined use, but the maximum level of that was same. In histological examination on day 7 afterthe administration, the infiltration of lymphocytes was found in a same extent.

Original languageEnglish
Pages (from-to)381-385
Number of pages5
JournalDrug Delivery System
Volume6
Issue number5
DOIs
Publication statusPublished - 1991

Fingerprint

Interleukin-2
Tumor Necrosis Factor-alpha
Sarcoma
Lymphocytes
Growth
Therapeutics

Keywords

  • combination immunotheropy
  • interleukin–2
  • tumor necrosis factor slow delivery

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Synergistic antitumor effects of tumor necrosis factor ALPHA. and interleukin 2 mini-pellet. / Onoda, Tadashi; Sakagami, Kenichi; Matsuoka, Junji; Shiozaki, Shigehiro; Uchida, Susumu; Fujiwara, Toshiyoshi; Orita, Kun Zou; Fujioka, Keiji; Takada, Yyshihiro.

In: Drug Delivery System, Vol. 6, No. 5, 1991, p. 381-385.

Research output: Contribution to journalArticle

Onoda, T, Sakagami, K, Matsuoka, J, Shiozaki, S, Uchida, S, Fujiwara, T, Orita, KZ, Fujioka, K & Takada, Y 1991, 'Synergistic antitumor effects of tumor necrosis factor ALPHA. and interleukin 2 mini-pellet', Drug Delivery System, vol. 6, no. 5, pp. 381-385. https://doi.org/10.2745/dds.6.381
Onoda, Tadashi ; Sakagami, Kenichi ; Matsuoka, Junji ; Shiozaki, Shigehiro ; Uchida, Susumu ; Fujiwara, Toshiyoshi ; Orita, Kun Zou ; Fujioka, Keiji ; Takada, Yyshihiro. / Synergistic antitumor effects of tumor necrosis factor ALPHA. and interleukin 2 mini-pellet. In: Drug Delivery System. 1991 ; Vol. 6, No. 5. pp. 381-385.
@article{5541484f6d494c8daa0eb8d97c7bfd3d,
title = "Synergistic antitumor effects of tumor necrosis factor ALPHA. and interleukin 2 mini-pellet",
abstract = "Synergistic antitumor effects of tumor necrosis factor α and interleukin 2 mini-pellet We have investigated the antitomor effect of IL 2 mini pellet on the therapy of murine Meth-A sarcoma in these years. In this study we used IL-2 mini-pellet with a small dose of nHuTNF-α and examined of its antitumor efficacy compared with the administration of IL-2 mini-pellet alone. Even a single administration of IL-2 mini pellet alone could inhibited the growth of Meth-A sarcoma that had transplanted in mice, the combined use was more effective. The lytic activity of splenocytes against YAC-1 cells was prolonged in the combined use, but the maximum level of that was same. In histological examination on day 7 afterthe administration, the infiltration of lymphocytes was found in a same extent.",
keywords = "combination immunotheropy, interleukin–2, tumor necrosis factor slow delivery",
author = "Tadashi Onoda and Kenichi Sakagami and Junji Matsuoka and Shigehiro Shiozaki and Susumu Uchida and Toshiyoshi Fujiwara and Orita, {Kun Zou} and Keiji Fujioka and Yyshihiro Takada",
year = "1991",
doi = "10.2745/dds.6.381",
language = "English",
volume = "6",
pages = "381--385",
journal = "Drug Delivery System",
issn = "0913-5006",
publisher = "Japan Society of Drug Delivery System",
number = "5",

}

TY - JOUR

T1 - Synergistic antitumor effects of tumor necrosis factor ALPHA. and interleukin 2 mini-pellet

AU - Onoda, Tadashi

AU - Sakagami, Kenichi

AU - Matsuoka, Junji

AU - Shiozaki, Shigehiro

AU - Uchida, Susumu

AU - Fujiwara, Toshiyoshi

AU - Orita, Kun Zou

AU - Fujioka, Keiji

AU - Takada, Yyshihiro

PY - 1991

Y1 - 1991

N2 - Synergistic antitumor effects of tumor necrosis factor α and interleukin 2 mini-pellet We have investigated the antitomor effect of IL 2 mini pellet on the therapy of murine Meth-A sarcoma in these years. In this study we used IL-2 mini-pellet with a small dose of nHuTNF-α and examined of its antitumor efficacy compared with the administration of IL-2 mini-pellet alone. Even a single administration of IL-2 mini pellet alone could inhibited the growth of Meth-A sarcoma that had transplanted in mice, the combined use was more effective. The lytic activity of splenocytes against YAC-1 cells was prolonged in the combined use, but the maximum level of that was same. In histological examination on day 7 afterthe administration, the infiltration of lymphocytes was found in a same extent.

AB - Synergistic antitumor effects of tumor necrosis factor α and interleukin 2 mini-pellet We have investigated the antitomor effect of IL 2 mini pellet on the therapy of murine Meth-A sarcoma in these years. In this study we used IL-2 mini-pellet with a small dose of nHuTNF-α and examined of its antitumor efficacy compared with the administration of IL-2 mini-pellet alone. Even a single administration of IL-2 mini pellet alone could inhibited the growth of Meth-A sarcoma that had transplanted in mice, the combined use was more effective. The lytic activity of splenocytes against YAC-1 cells was prolonged in the combined use, but the maximum level of that was same. In histological examination on day 7 afterthe administration, the infiltration of lymphocytes was found in a same extent.

KW - combination immunotheropy

KW - interleukin–2

KW - tumor necrosis factor slow delivery

UR - http://www.scopus.com/inward/record.url?scp=85010168252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010168252&partnerID=8YFLogxK

U2 - 10.2745/dds.6.381

DO - 10.2745/dds.6.381

M3 - Article

AN - SCOPUS:85010168252

VL - 6

SP - 381

EP - 385

JO - Drug Delivery System

JF - Drug Delivery System

SN - 0913-5006

IS - 5

ER -